These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24454715)

  • 21. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
    Plecha D; Bai S; Patterson H; Thompson C; Shenk R
    Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results.
    Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A
    AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
    Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
    Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
    Kato F; Kudo K; Yamashita H; Baba M; Shimizu A; Oyama-Manabe N; Kinoshita R; Li R; Shirato H
    Breast Cancer; 2019 Sep; 26(5):628-636. PubMed ID: 30937834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do?
    Leenders MW; Broeders M; Croese C; Richir MC; Go HL; Langenhorst BL; Meijer S; Schreurs WH
    Breast; 2012 Aug; 21(4):578-83. PubMed ID: 22717665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-modal computer-assisted evaluation of axillary lymph node metastasis in breast cancer patients on both real-time elastography and B-mode ultrasound.
    Zhang Q; Suo J; Chang W; Shi J; Chen M
    Eur J Radiol; 2017 Oct; 95():66-74. PubMed ID: 28987700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
    Fornasa F; Nesoti MV; Bovo C; Bonavina MG
    J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
    Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
    Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
    Sandoughdaran S; Malekzadeh M; Mohammad Esmaeil ME
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1617-1620. PubMed ID: 29936787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
    Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
    Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.
    Okamoto T; Yamazaki K; Kanbe M; Kodama H; Omi Y; Kawamata A; Suzuki R; Igari Y; Tanaka R; Iihara M; Ito Y; Sawada T; Nishikawa T; Maki M; Kusakabe K; Mitsuhashi N; Obara T
    Breast Cancer; 2005; 12(3):203-10. PubMed ID: 16110290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
    Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.